Page 25 - Exact Sciences Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Search jobs 29-Jan-2021 Breast Cancer Diagnostic Market Research Based on Synthesis and Analysis on Techniques and Medical Applications Report 2019 – 2026 Breast cancer is a cancer that forms in cells of the breasts. It is characterized by a malignant tumor formed in the breast cells, which can spread to other parts of the body. It is typically observed in females and is diagnosed by doctors with the help of several tests to locate the site of initiation and the spread of the tumor to several parts of the body. Various symptoms are observed in br...

/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has acquired a worldwide exclusive license to the proprietary TARDIS technology...

Share this article Share this article MADISON, Wis., Jan. 12, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) announced data published today in Cancer Prevention Research, a Journal of the American Association for Cancer Research, that expands on foundational clinical study findings to include a key younger population. Study results show that among average-risk adults between the ages of 45 and 49 Cologuard® (mt-sD­­­­NA) demonstrated test specificity of 95.2% in participants with non-advanced precancerous lesions or negative findings at colonoscopy and 96.3% in only those with...

Exact Sciences Announces Preliminary Fourth Quarter 2020 Results - Expected total revenue of $464.5-467.5M, including Screening revenue of $249-250M, Precision Oncology revenue of $117-118M, and COVID-19 testing revenue of $98.5-99.5M News provided by Share this article Share this article MADISON, Wis., Jan. 10, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company expects to report revenue between $464.5 million and $467.5 million for the fourth quarter ended Dec. 31, 2020. "I'm incredibly proud of how the Exact Sciences team came together during 2020 to ...

Search jobs 08-Jan-2021 Global Genetic Testing Market 2021 Size & Trends Shows a Rapid Growth by 2028 || 23andMe, Inc., Abbott., Ambry Genetics., BGI, Biocartis, BIO-HELIX This Global Genetic Testing Market research report focuses on the market and delivers a detailed analysis of the market and future prospects of the global market. The critical and significant data in the study makes the research a very vital tool for the experts and analysts and managers to get ready to access analysis by the industry professionals. The Global Genetic Testing Mar...